Literature DB >> 22127435

In vitro mitochondrial effects of PK 11195, a synthetic translocator protein 18 kDa (TSPO) ligand, in human osteoblast-like cells.

Nahum Rosenberg1, Orit Rosenberg, Abraham Weizman, Svetlana Leschiner, Yaakov Sakoury, Fuad Fares, Michael Soudry, Gary Weisinger, Leo Veenman, Moshe Gavish.   

Abstract

The role of the TSPO in metabolism of human osteoblasts is unknown. We hypothesized that human osteoblast metabolism may be modulated by the TSPO. Therefore we evaluated the presence of TSPO in human osteoblast-like cells and the effect of its synthetic ligand PK 11195 on these cells. The presence of TSPO was determined by [(3)H]PK 11195 binding using Scatchard analysis: Bmax 7682 fmol/mg, Kd 9.24 nM. PK 11195 did not affect significantly cell proliferation, cell death, cellular viability, maturation, [(18)F]-FDG incorporation and hexokinase 2 gene expression or protein levels. PK 11195 exerted a suppressive effect on VDAC1 and caused an increase in TSPO gene expression or protein levels. In parallel there was an increase in mitochondrial mass, mitochondrial ATP content and a reduction in ΔΨm collapse. Thus, it appears that PK11195 (10(-5) M) stimulates mitochondrial activity in human osteoblast-like cells without affecting glycolytic activity and cell death.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127435     DOI: 10.1007/s10863-011-9388-x

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  32 in total

1.  The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.

Authors:  Rami Shoukrun; Leo Veenman; Yulia Shandalov; Svetlana Leschiner; Ilana Spanier; Rachel Karry; Yeshayahu Katz; Gary Weisinger; Abraham Weizman; Moshe Gavish
Journal:  Pharmacogenet Genomics       Date:  2008-11       Impact factor: 2.089

2.  Characterization of peripheral benzodiazepine binding sites in human term placenta.

Authors:  F Fares; M Gavish
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

3.  Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity.

Authors:  R J Gay; R B McComb; G N Bowers
Journal:  Clin Chem       Date:  1968-08       Impact factor: 8.327

Review 4.  Peripheral benzodiazepine receptors and mitochondrial function.

Authors:  Pierre Casellas; Sylvaine Galiegue; Anthony S Basile
Journal:  Neurochem Int       Date:  2002-05       Impact factor: 3.921

5.  PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) protein components in the rat brain.

Authors:  L Veenman; S Leschiner; I Spanier; G Weisinger; A Weizman; M Gavish
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

Review 6.  Regulation of hexokinase binding to VDAC.

Authors:  John G Pastorino; Jan B Hoek
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

7.  Presence of peripheral benzodiazepine binding sites on primary rat skeletal fibroblasts.

Authors:  B A Weissman; H F Elson; D Kaplan; A H Newman
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

8.  Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Tatiana Sheiko; William J Craigen; Jeffery D Molkentin
Journal:  Nat Cell Biol       Date:  2007-04-08       Impact factor: 28.824

9.  Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.

Authors:  Leo Veenman; Julia Alten; Karen Linnemannstöns; Yulia Shandalov; Sivan Zeno; Max Lakomek; Moshe Gavish; Wilfried Kugler
Journal:  Apoptosis       Date:  2010-07       Impact factor: 4.677

10.  A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1).

Authors:  A Cossarizza; M Baccarani-Contri; G Kalashnikova; C Franceschi
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

View more
  8 in total

1.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

2.  In vitro catabolic effect of protoporphyrin IX in human osteoblast-like cells: possible role of the 18 kDa mitochondrial translocator protein.

Authors:  Nahum Rosenberg; Orit Rosenberg; Abraham Weizman; Leo Veenman; Moshe Gavish
Journal:  J Bioenerg Biomembr       Date:  2013-03-09       Impact factor: 2.945

3.  In vitro effect of FGIN-1-27, a ligand to 18 kDa mitochondrial translocator protein, in human osteoblast-like cells.

Authors:  Nahum Rosenberg; Orit Rosenberg; Abraham Weizman; Leo Veenman; Moshe Gavish
Journal:  J Bioenerg Biomembr       Date:  2014-02-18       Impact factor: 2.945

4.  Osteoblasts in bone physiology-mini review.

Authors:  Nahum Rosenberg; Orit Rosenberg; Michael Soudry
Journal:  Rambam Maimonides Med J       Date:  2012-04-30

Review 5.  Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic Ligands.

Authors:  Leo Veenman; Alex Vainshtein; Nasra Yasin; Maya Azrad; Moshe Gavish
Journal:  Int J Mol Sci       Date:  2016-06-04       Impact factor: 5.923

6.  Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling.

Authors:  Nasra Yasin; Leo Veenman; Sukhdev Singh; Maya Azrad; Julia Bode; Alex Vainshtein; Beatriz Caballero; Ilan Marek; Moshe Gavish
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

7.  The translocator protein ligands as mitochondrial functional modulators for the potential anti-Alzheimer agents.

Authors:  TaeHun Kim; Mohammad N Morshed; Ashwini M Londhe; Ji W Lim; Ha E Lee; Suengmok Cho; Sung J Cho; Hayoung Hwang; Sang M Lim; Jae Y Lee; Jiyoun Lee; Ae N Pae
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

8.  PK11195 Protects From Cell Death Only When Applied During Reperfusion: Succinate-Mediated Mechanism of Action.

Authors:  Lea K Seidlmayer; Benjamin J Hanson; Phung N Thai; Saul Schaefer; Donald M Bers; Elena N Dedkova
Journal:  Front Physiol       Date:  2021-05-04       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.